| abstract |
Provided are prophylactic and therapeutic methods of treatment of subjects for the purpose of inhibiting vaso-oc-clusive events, including embolism, by administering agents, including anagrelide and anagrelide derivatives, which reduce the number of circulating platelets to low normal or to below normal levels. Methods and pharmaceutical preparations comprising such agents are provided. |